NKTR News

ROSEN, A LEADING AND RANKED FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

Pomerantz LLP Moves Forward with Class Action Litigation Against Nektar Therapeutics – NKTR

ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

Pomerantz LLP Pursues Class Action Against Nektar Therapeutics – NKTR

NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Moves Forward with Class Action Lawsuit Against Nektar Therapeutics – NKTR

Pomerantz LLP Moves to File Class Action Litigation Against Nektar Therapeutics – NKTR

LU INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Lufax (LU) Investors of Securities Class Action Deadline on May 20, 2026 Ready to Announce with Confidence?

NAVN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Navan (NAVN) Investors of Securities Class Action Deadline on April 24, 2026 Ready to Announce with Confidence?

NKTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 Ready to Announce with Confidence?